PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Sleep Med. Author manuscript; available in PMC 2010 May 1.
Published in final edited form as:
PMCID: PMC2735085
NIHMSID: NIHMS120347

NOCTURIA AND DISTURBED SLEEP IN THE ELDERLY

Abstract

Background

Nocturnal urination (nocturia) is such a commonplace occurrence in the lives of many older adults that it is frequently overlooked as a potential cause of sleep disturbance.

Methods

We examined the prevalence of nocturia and examined its role in self-reported insomnia and poor sleep quality in a survey of 1,424 elderly individuals, ages 55–84. Data were derived from a 2003 National Sleep Foundation telephone poll conducted in a representative sample of the United States population who underwent a 20-minute structured telephone interview. Nocturia was not a focus of the survey, but data collected relevant to this topic allowed examination of relevant associations with sleep.

Results

When inquired about in a checklist format, nocturia was listed as a self-perceived cause of nocturnal sleep “every night or almost every night” by 53% of the sample, which was over four times as frequently as the next most often cited cause of poor sleep, pain (12%). In multivariate logistic models, nocturia was an independent predictor both of self-reported insomnia (75% increased risk) and reduced sleep quality (71% increased risk), along with female gender and other medical and psychiatric conditions.

Conclusions

Nocturia is a frequently overlooked cause of poor sleep in the elderly and may warrant targeted interventions.

MeSH Keywords: Aging, Health Survey, Nocturia, Sleep Initiation and Maintenance Disorders, Prostatism, Falls

INTRODUCTION

Nocturnal urination (nocturia) is a mundane event in the lives of many older adults. It is frequently overlooked as a potential cause of poor sleep both by elderly persons, who view the phenomenon as an inevitable consequence of growing old, and by researchers, who may minimize the importance of nocturnal awakenings because of nocturia (13). Among the population, the phenomenon of nightly awakenings for bathroom trips has become so commonplace that it can essentially be considered a cultural “norm” or expectation among older persons. Multiple, overlapping causes of frequent urination at night in the aged population have been described, including loss of bladder capacity, decreased glomerular filtration rate, and nocturnal polyuria from decreased arginine vasopressin, incipient diabetes, sleep disordered breathing, congestive heart failure and/or diuretic use (4). Gender-specific causes have also been identified, including benign prostatic hypertrophy in men and vaginal atrophy and resulting reduced sphincter control in women. Despite such elucidation of underlying mechanisms, the significance of nocturia for disturbed sleep remains unclear. This is particularly true when viewed in the context of other highly prevalent morbidities well-acknowledged to be associated with sleep disturbance (c.f., chronic pain) (5). In this report, we examined prevalence and correlates of nocturia with special emphasis on how this phenomenon was related to disturbed sleep in an elderly population.

METHODS

Data were derived from the 2003 National Sleep Foundation’s (NSF) annual Sleep in America Poll. This was a telephone-based, 20-minute interview (full copy available on request) consisting of a random sample of phone numbers of United States households employing age (three groups) and gender (two groups) quota sampling by region, based on 2000 Bureau of Census data. The targeted sample was 1500 non-institutionalized, elderly participants between the ages of 55 and 84 inclusive. Interviews were conducted between September 17 and December 10, 2002. Nearly 80% of interviews were conducted on weekdays between 5:00 PM and 8:00 PM, Saturdays between 10:00 AM and 4:00 PM, and Sundays between 4:00 PM and 8:00 PM. When a household was reached, a query was made regarding whether an individual between the ages of 55 and 84 inclusive resided in the household, and the individual of that age with the most recent birthday was identified as the targeted interview. Proxy responses were not allowed. Interview response rate was 26%, yielding 1,506 interviews, of which 1,424 (823 women, 601 men) had complete data for use in the current analyses. Questions employed in the current analyses are shown in the Appendix. Statistical analyses consisted of two × two contingency tables to describe bivariate relationships and odds ratios between pairs of relevant variables. We performed logistic regressions predicting self-reported insomnia and poor sleep quality as related to various medical conditions.

APPENDIX
Items from the National Sleep Foundation Poll Used in the Current Analyses

RESULTS

Table 1 shows the prevalence of the participants who incurred self-defined insomnia, poor sleep, and nocturia. Based on these results, we combined fair and poor sleep quality into a single category for low sleep quality and considered bathroom frequency of every night or almost every night as positive for nocturia. For all three questions in Table 1, “don’t know” and individuals refusing to answer were dropped from these and all subsequent analyses. Bivariate analyses of these categories indicated that individuals with nocturia (i.e., every night or almost every night) were more likely to define themselves as having insomnia (22.5% for those with nocturia, 13.0% for those without nocturia, χ2 = 21.47, p < .0001) and more likely to report low sleep quality (27.3% for those with nocturia, 16.7% for those without nocturia, χ2 = 22.87, p < .0001).

Table 1
Prevalence of Insomnia, Poor Sleep Quality and Nocturia

Table 2 indicates the relative prevalence of the nine other items constituting self-reported causes of poor sleep in the participants. With the exception of physical pain, the proportion of the population reporting that a particular symptom or condition disturbed their sleep on an every night or almost every night basis was very low (4% or less). Even pain was reported by only 12% of the participants as disturbing sleep on this frequent a basis. When compared to the endorsement of nocturia (53%) these differences were striking and reiterated the commonplace nature of awakenings to void from sleep.

Table 2
Prevalence (%) of Other Self-Reported Causes of Disturbed Sleep

As would be expected in a population in this age range, medical conditions were highly prevalent (Table 3). These estimates are derived from self-reports and may be subject to error; although the fact that participants were required to indicate that a condition was both diagnosed and treated probably results in these figures being somewhat conservative. Univariate and multivariate models predicting both self-reported insomnia and poor sleep by gender, nocturia and these comorbid medical conditions are shown in Tables 4 and and5.5. Consistent with many other epidemiologic studies (5), being female, depression and conditions involving chronic pain were associated with disturbed sleep. In both of these models nocturia remained an independent predictor of poor sleep.

Table 3
Prevalence of Medical Conditions*
Table 4
Prediction of Self-Reported Insomnia
Table 5
Prediction of Self-Reported Poor Sleep Quality

A final set of analyses was limited to men and incorporated prostatism. Men with a history of diagnosis and treatment for enlarged prostate were significantly more likely to report nocturia, relative to men without such history (67.3% vs. 48.0%, χ2 = 7.44, p < .01). In multivariate models, nocturia continued to be predictive (Table 6), suggesting that ongoing treatments for presumed prostatic hypertrophy were unsuccessful in modifying nocturnal voiding and/or that the association of nocturnal voiding with sleep disturbance exceeded the importance of the diagnosis of prostatism per se.

Table 6
Multivariate Prediction (Including Prostatism) of Insomnia and Poor Quality Sleep in Males (n=601)

DISCUSSION

Given the robustness of nocturia as a predictor of poor sleep in this population, it is indeed curious why many well-done epidemiologic studies have minimized or even ignored its potential causal role for disturbed sleep in the nocturnal lives of older persons (e.g., 1). Without imputing intent for this general omission, one could speculate regarding several bases for its occurrence. Even if elderly subjects readily acknowledge that nocturia may awaken them frequently at night, it could be contended that, because most individuals return to sleep easily after nocturnal voids, this phenomenon does not carry import as a cause of disturbed sleep. Because the NSF poll did not specifically inquire about difficulty in returning to sleep (nocturia was presented simply in checklist format along with other medical conditions), we cannot eliminate this possibility. However, several aspects of our analyses would argue against such an interpretation. First, it is clear that within the NSF data, both self-defined low sleep quality and self-defined insomnia are predicted by nighttime bathroom trips in multivariate models, implying that nocturnal voids indeed impact an individual’s perception of their own sleep however that is to be defined. Secondly, although the survey did not ask specifically about whether individuals did or did not have difficulty returning to sleep after voiding, participants responded to the nocturia item on the checklist with vastly higher relative endorsement rates than other well-acknowledged causes of nocturnal sleep disturbance, such as pain, heartburn, and caregiving duties, which were inquired about in an identical format. Valid identification of these better recognized causes of sleep disturbance does not typically consider the additional qualification of difficulty returning to sleep to be a relevant cause for sleep disturbance. It should be pointed out that the definition of nocturia suggested by the International Continence Society (ICS) (6) stipulates that the voiding episode must be both preceded by and followed by sleep, though it also does not include criteria regarding relative ease or difficulty in returning to sleep.

Another explanation as to why researchers have failed to recognize nocturia as a major cause of disturbed sleep in the elderly may reflect a pervasive assumption that nocturia episodes occur secondary to awakenings from other causes. To paraphrase, an elderly individual may awaken from a variety of other causes that remain unknown to them, perceive the need to void, and then make a bathroom trip (7). One study suggested that subjects could identify the basis for their awakening in only 5% of awakenings (7). Perhaps as a consequence, older persons may attribute their awakenings to the need to use the bathroom “after the fact” (7). There is no shortage of factors that result in nocturnal awakenings in the elderly population. These may include age-dependent intrinsic lightening of sleep homeostatic processes (8,9), chonobiologic changes (10), higher susceptibility to arousal from sources such as noise and light (11, 12), awakenings from primary medical conditions (e.g., osteoarthritis, gastroesophageal reflux) (13, 14), or specific sleep disorders such as sleep apnea (1517). In this scenario, an older individual may awaken from one or more of these causes, perceive a full bladder, and then voluntarily elect to arise from bed and void. Nocturia may thus represent an outcome of sleep disturbance, rather than its cause. Observational data cannot fully address these issues of causality. The only conclusive way to examine such possibilities would be clinical trials in elderly populations that either: (a) manipulate bladder function and examine sleep disturbance as an outcome or (b) manipulate sleep disturbance and examine nocturia (bathroom trips) as an outcome.

Surprisingly few existing studies have been performed addressing either of the aforementioned approaches. Regarding possibility (a), several trials of muscarinic antagonists and desmopressin including sizeable numbers of adults age 50 and above have reported longer duration of first sleep episode before first nocturnal void (1821), reduced diary-defined number of awakenings (22) or global self-reported improvements in sleep (2327), but at least one trial showed apparent worsening of sleep due to dry mouth from such medication (28). Daytime behavioral interventions targeting nocturnal bladder control in incontinent geriatric patients have shown mixed results on nocturnal incontinence and do not assess sleep per se (29), though one nocturnal incontinence intervention noted fewer awakenings at night (12). Even fewer studies have addressed possibility (b); however, decreased nocturia episodes and nocturnal urine production have been associated with successful treatment of sleep apnea with nasal continuous positive airway pressure (15, 30, 31). Song et al. (32) reported that concurrent use of zolpidem and an alpha-blocker resulted in a greater reduction in nocturia episodes than alpha blockade alone, whereas Sugaya et al. (33) showed that exercise, which presumably solidified nocturnal sleep, resulted in decreased nocturia episodes. Other than such studies involving a specific sleep disorder and specific modality of treatment, we are not aware of any sedative/hypnotic or behavioral intervention trials for primary or comorbid insomnia (out of many hundreds performed) that have used nocturnal voids as an outcome. Thus, clarification as to whether nocturia is a cause or effect of disturbed sleep by reference to a limited number of relevant clinical trials remains equivocal at present.

Apart from causal issues, a systematic review of other population-based studies mentioning nocturia provides remarkably consistent results in associations with disturbed sleep. First, there can be little doubt that the prevalence of nocturia increases substantially with age in both men and women. Brocklehurst et al. (34) appeared among the first to specifically inquire about nocturia, noting that about 45% of patients over the age of 65 in a general medical practice in England had two or more bathroom trips per night. These figures generally have been supported by more recent epidemiologically based studies. In a nationally representative sample of the United States population (n = 5,204), Coyne et al. (35) reported that two or more nocturnal voids occurred in about 25% of the 65–74 year old population and in about 35% of the population over the age of 75. Two or more voids per night were associated with lower total sleep times and higher scores of sleep complaints on the Medical Outcomes Study Sleep Questionnaire. In a report of data derived from the NSF Poll predating the current work, Foley et al. (36) noted that nocturia (defined using the same item as employed in the current analyses) was associated with daytime napping. Asplund and Aberg (37) provided detailed data in a Swedish population that indicated that the number of nocturnal voids (none, one, two, three or more) showed graded levels of endorsement to questions regarding sleeping poorly at night, increased awakenings at night, difficulty returning to sleep and greater levels of daytime tiredness. In a later study with over 10,000 elderly participants, Asplund (38) noted that respondents with three or more nocturnal voids were more likely to have poor sleep, have cardiovascular disease and be diabetic. Rembratt et al. (39) reported that nocturia and poor sleep were related independently of other medical conditions that might be expected to result in nocturnal voiding, such as congestive heart failure, diabetes and diuretics. Middlekoop et al. (40) showed that nocturia was by far the most commonly cited reason (67.5%) for disturbed sleep maintenance in a study of over 1,400 Dutch residents ages 50–93, with prevalence of the phenomenon increasing with age. Virtually identical prevalence figures were noted in an Italian cohort (41) where 73.3% of men and 57.8% of women reported that their nightly awakenings were caused by need to void, whereas no other cause (pain, gastrointestinal symptoms, rumination, anxiety) exceeded 10%. Figures of 77% (men) and 74% (women) were more recently reported in a Danish population (42). Several recent studies using standard psychometric instruments such as the Pittsburgh Sleep Quality Index (43), Medical Outcomes Study Sleep Scale (44) and Nordic Sleep Questionnaire (45) also have shown associations with lower sleep quality. We emphasize that neither these nor any of the other studies that have mentioned nocturia (4651) have employed the multivariate modeling that we have used here, which otherwise allows the relative role of nocturia for poor sleep to be better understood, particularly in the context of other risk factors for compromised sleep quality.

Every bed rise episode and bathroom trip represents a potential exposure for a fall. Urge incontinence irregardless of time of day has been associated with falls (5254), and several studies have shown that nocturia per se is also a risk factor for falls (5557). Stewart et al. (55) reported that individuals who voided two times a night incurred elevated fall risk (Odds Ratio = 1.84), which was even higher with three or more voids per night (Odds Ratio = 2.15) over an interval of five years, and Asplund (56) recently reported similar results indicating that three or more voids per night increased a risk for hip fracture by 80%. The majority of nocturnal falls occurred in conjunction with bathroom trips, relative to less than 20% of daytime falls (57). These findings are compatible with other data suggesting that that insomnia and sleep disturbance (without specific reference to nocturnal voiding) may also be a risk for falls in community-dwelling populations (58, 59), even apart from medication use. In essence, being awake at night for any reason increases the exposure for falls by increasing the likelihood of bedrise episodes. These data raise the logical, but seemingly heretical, possibility that effective pharmacologic treatments for disturbed sleep and nocturia, counter to many studies suggesting adverse events associated with their use on a population-wide basis (6062), could be associated with a reduction in falls if efficacy for a given patient on a given night was successful in keeping the person asleep and in bed. Such a possibility was recently suggested by a retrospective analysis of sleep disturbance in nursing homes using the Healthcare Financing Administration mandated Minimal Data Set from over 34,000 nursing home patients in the state of Michigan (63).

Limitations of the NSF survey involve the relatively low response rate (26%) and the nature of the polling process that generated the current data. Polls, by their very nature, involved quota filling, rather than sample weighing, which is then used to construct a demographically representative population sample. Within the limitations of age, geography and gender, these data may be considered roughly representative of the independently living population (ages 55–84) residing in the particular locales from which it sampled. However, the quota sampling procedure only approximates the population and cannot be considered to represent a true random probability sample. Certain other constraints must be acknowledged. The polling procedure did not employ quotas for race or ethnicity, thus, in all likelihood, it underrepresented selected racial groups. Given these constraints and the limited geographical regions sampled within the United States (Northeast, Southwest, Midwest, Far West), the data are probably best considered as roughly representative of non-minority elderly individuals with land-line telephones residing in those regions. Individuals residing within institutions or facilities (e.g., nursing homes, assisted living facilities) were excluded perforce, unless that individual had a private telephone number. Medical diagnoses were defined via self-report and in some cases may have been quite imprecise and inaccurate, particularly as they relate to nocturia (e.g., prostatism) (64, 65). As mentioned previously, the NSF Poll did not specifically gather data related to difficulty falling back to sleep after nocturnal voiding trips, nor did the survey collect data on the number of nocturia episodes, a relevant point because several studies (35, 37) demonstrated a near-linear increase in the likelihood of poor sleep in relation to the number of nocturnal voids. The definition of nocturia used in the Poll also differed from the definition established by the International Continence Society (6), which defined nocturia as awakening one or more times per night for the purpose of voiding with an intention to return to sleep, but did not otherwise specify criteria to define length of time to return to sleep or the quantity of sleep that would occur subsequent to such bathroom trips. Such issues might also be important in determining whether nocturia defined in this manner was related to lower sleep quality. Future surveys examining nocturia and disturbed sleep should examine such phenomena in greater detail.

Acknowledgments

Support: National Institutes of Health Grants AG-020269 (to D.L.B); AG-08415 (to S.A-I); MH-001158 (to M.V.V); and the National Sleep Foundation

The authors thank Patricia Britz of the National Sleep Foundation and Dr. Andrew Monjan of the National Institute on Aging for their assistance with this work.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

1. Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995 Jul;18(6):425–432. [PubMed]
2. Enright PL, Newman AB, Wahl PW, Manolio TA, Haponik EF, Boyle PJ. Prevalence and correlates of snoring and observed apneas in 5,201 older adults. Sleep. 1996 Sep;19(7):531–538. [PubMed]
3. Newman AB, Spiekerman CF, Enright P, et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc. 2000 Feb;48(2):115–123. [PubMed]
4. Miller M. Nocturnal polyuria in older people: pathophysiology and clinical implications. J Am Geriatr Soc. 2000 Oct;48(10):1321–1329. [PubMed]
5. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med. 1998 May 25;158(10):1099–1107. [PubMed]
6. Van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardisation of terminology in nocturia; report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:179–83. [PubMed]
7. Pressman MR, Figueroa WG, Kendrick-Mohamed J, Greenspon LW, Peterson DD. Nocturia. A rarely recognized symptom of sleep apnea and other occult sleep disorders. Arch Intern Med. 1996 Mar 11;156(5):545–550. [PubMed]
8. Dijk DJ, Duffy JF, Riel E, Shanahan TL, Czeisler CA. Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms. J Physiol. 1999 Apr 15;516 ( Pt 2):611–627. [PubMed]
9. Dijk DJ, Duffy JF, Czeisler CA. Age-related increase in awakenings: impaired consolidation of nonREM sleep at all circadian phases. Sleep. 2001;24:565–577. [PubMed]
10. Bliwise DL. Sleep and circadian rhythm disorders in aging and dementia. In: Turek F, Zee P, editors. Regulation of Sleep and Circadian Rhythms. New York: Marcel Dekker; 1999. pp. 487–582.
11. Zepelin H, McDonald CS, Zammit GK. Effects of age on auditory awakening thresholds. J Gerontol. 1984 May;39(3):294–300. [PubMed]
12. Schnelle JF, Cruise PA, Alessi CA, Al-Samarrai N, Ouslander JG. Individualizing nighttime incontinence care in nursing home residents. Nurs Res Jul-Aug. 1998;47(4):197–204. [PubMed]
13. Wilcox S, Brenes GA, Levine D, Sevick MA, Shumaker SA, Craven T. Factors related to sleep disturbance in older adults experiencing knee pain or knee pain with radiographic evidence of knee osteoarthritis. J Am Geriatr Soc. 2000 Oct;48(10):1241–1251. [PubMed]
14. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol. 2003 Jul;98(7):1487–1493. [PubMed]
15. Krieger J, Petiau C, Sforza E, Delanoe C, Hecht MT, Chamouard V. Nocturnal pollakiuria is a symptom of obstructive sleep apnea. Urol Int. 1993;50(2):93–97. [PubMed]
16. Hajduk IA, Strollo PJ, Jr, Jasani RR, Atwood CW, Jr, Houck PR, Sanders MH. Prevalence and predictors of nocturia in obstructive sleep apnea-hypopnea syndrome--a retrospective study. Sleep. 2003 Feb 1;26(1):61–64. [PubMed]
17. Endeshaw YW, Johnson TM, Kutner MH, Ouslander JG, Bliwise DL. Sleep-disordered breathing and nocturia in older adults. J Am Geriatr Soc. 2004 Jun;52(6):957–960. [PubMed]
18. Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int. 2002 Jun;89(9):855–862. [PubMed]
19. Lose G, Lalos O, Freeman RM, van Kerrebroeck P. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol. 2003 Oct;189(4):1106–1113. [PubMed]
20. Margel D, Lifshitz D, Brown N, Lask D, Livne PM, Tal R. Predictors of nocturia quality of life before and shortly after prostatectomy. Urology. 2007;70:493–7. [PubMed]
21. Van Kerrebroeck P, Rezapour M, Cortesse A, Thuroff J, Riis A, Norgaard JP. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. Eur Urol. 2007;52:221–29. [PubMed]
22. Hill S, Khullar V, Wyndaele J-J, Lheritier K. Dose response with darifenacin, a novel once-daily M3 selective receptor antagonist for the treatment of overactive bladder: results of a fixed dose study. Int Urogynecol J. 2006;17:239–47. [PubMed]
23. Kelleher CJ, Kreder KJ, Pleil AM, Burgess SM, Reese PR. Long-term health- related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care. 2002 Dec;8(19 Suppl):S616–630. [PubMed]
24. Kelleher CJ, Cardozo L, Chapple CR, Haab F, Ridder AM. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int. 2005 Jan;95(1):81–85. [PubMed]
25. Garely AD, Lucente V, Vapnek J, Smith N. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes. Ann Pharmacother. 2007;41:391–9. [PubMed]
26. Galely AD, Kaufman JM, Sand PK, Smith N, Andoh M. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare open-label trial (VOLT) Clin Ther. 2006;28:1935–46. [PubMed]
27. Nixon A, Colman S, Sabounjian L, Sandage B, Schwiderski UT, Staskin DR, Zinner N. A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol. 2005;174:604–7. [PubMed]
28. Leung HY, Yip SK, Cheon C, et al. A randomized controlled trial of tolterodine and oxybutynin on tolerability and clinical efficacy for treating Chinese women with an overactive bladder. BJU Int. 2002 Sep;90(4):375–380. [PubMed]
29. Ouslander JG, Ai-Samarrai N, Schnelle JF. Prompted voiding for nighttime incontinence in nursing homes: is it effective? J Am Geriatr Soc. 2001 Jun;49(6):706–709. [PubMed]
30. Umlauf MG, Burgio KL, Shettar S, Pillion D. Nocturia and nocturnal urine production in obstructive sleep apnea. Appl Nurs Res. 1997 Nov;10(4):198–201. [PubMed]
31. Kiely JL, Murphy M, McNicholas WT. Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J. 1999 May;13(5):1086–1090. [PubMed]
32. Song YS, Ku JH. Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study. Int Urol Nephrol. 2007;39:1147–52. [PubMed]
33. Sugaya K, Nishijima S, Owan T, Oda M, Miyazato M, Ogawa Y. Effects of walking exercise on nocturia in the elderly. Biomed Res. 2007;28:101–5. [PubMed]
34. Brocklehurst JC, Fry J, Griffiths LL, Kalton G. Dysuria in old age. J Am Geriatr Soc. 1971 Jul;19(7):582–592. [PubMed]
35. Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int. 2003 Dec;92(9):948–954. [PubMed]
36. Foley DJ, Vitiello MV, Bliwise DL, Ancoli-Israel S, Monjan AA, Walsh JK. Frequent napping is associated with excessive daytime sleepiness, depression, pain and nocturia in older adults: findings from the National Sleep Foundation “2003 Sleep in America” poll. Am J Geriatr Psychiatry. 2007;15:344–350. [PubMed]
37. Asplund R, Aberg H. Health of the elderly with regard to sleep and nocturnal micturition. Scand J Prim Health Care. 1992 Jun;10(2):98–104. [PubMed]
38. Asplund R. Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly. BJU Int. 2002 Oct;90(6):533–536. [PubMed]
39. Rembratt A, Norgaard JP, Andersson KE. Nocturia and associated morbidity in a community-dwelling elderly population. BJU Int. 2003 Nov;92(7):726–730. [PubMed]
40. Middelkoop HA, Smilde-van den Doel DA, Neven AK, Kamphuisen HA, Springer CP. Subjective sleep characteristics of 1,485 males and females aged 50–93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol A Biol Sci Med Sci. 1996 May;51(3):M108–115. [PubMed]
41. Maggi S, Langlois JA, Minicuci N, et al. Sleep complaints in community-dwelling older persons: prevalence, associated factors, and reported causes. J Am Geriatr Soc. 1998 Feb;46(2):161–168. [PubMed]
42. Bing MH, Moller LA, Jennum P, Mortensen S, Skovgaard LT, Lose G. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60–80 years. BJU Int. 2006;98:599–604. [PubMed]
43. Cai T, Gardener N, Abraham L, Boddi V, Abrams P, Bartoletti R. Impact of surgical treatment on nocturia in men with benign prostatic obstruction. BJU Int. 2006;98:799–805. [PubMed]
44. Lau DT, Morlock RJ, Hill CD. Psychometric evaluation of the Medical Outcomes Study-Sleep Scale in persons with overactive bladder. Clin Ther. 2006;28:2119– 32. [PubMed]
45. Drake NL, Flynn MK, Romero AA, Weidner AC, Amundsen CL. Nocturnal polyuria in women with overactive bladder symptoms and nocturia. Am J Obstet Gynecol. 2005;192:1682–6. [PubMed]
46. Johnson JE. Sleep and alcohol use in rural old-old women. J Community Health Nurs. 1994;11(4):211–218. [PubMed]
47. Clapin-French E. Sleep patterns of aged persons in long-term care facilities. J Adv Nurs. 1986 Jan;11(1):57–66. [PubMed]
48. Gentili A, Weiner DK, Kuchibhatil M, Edinger JD. Factors that disturb sleep in nursing home residents. Aging (Milano) 1997 Jun;9(3):207–213. [PubMed]
49. Friedman LF, Bliwise DL, Tanke ED, Salom SR, Yesavage JA. A survey of self-reported poor sleep and associated factors in older individuals. Behavior, Health and Aging. 199192;2(1):13–20.
50. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May;20(6):327–336. [PubMed]
51. Ito Y, Tamakoshi A, Yamaki K, et al. Sleep disturbance and its correlates among elderly Japanese. Arch Gerontol Geriatr Mar-Apr. 2000;30(2):85–100. [PubMed]
52. Kutner NG, Schechtman KB, Ory MG, Baker DI. Older adults' perceptions of their health and functioning in relation to sleep disturbance, falling, and urinary incontinence.FICSIT Group. J Am Geriatr Soc. 1994 Jul;42(7):757–762. [PubMed]
53. Brown JS, Vittinghoff E, Wyman JF, et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 2000 Jul;48(7):721–725. [PubMed]
54. Wagner TH, Hu TW, Bentkover J, et al. Health-related consequences of overactive bladder. Am J Manag Care. 2002 Dec;8(19 Suppl):S598–607. [PubMed]
55. Stewart RB, Moore MT, May FE, Marks RG, Hale WE. Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc. 1992 Dec;40(12):1217–1220. [PubMed]
56. Asplund R. Hip fractures, nocturia, and nocturnal polyuria in the elderly. Arch Gerontol Geriatr. 2006;43:319–26. [PubMed]
57. Jensen J, Lundin-Olsson L, Nyberg L, Gustafson Y. Falls among frail older people in residential care. Scand J Public Health. 2002;30(1):54–61. [PubMed]
58. Brassington GS, King AC, Bliwise DL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64–99 years. J Am Geriatr Soc. 2000 Oct;48(10):1234–1240. [PubMed]
59. Koski K, Luukinen H, Laippala P, Kivela SL. Risk factors for major injurious falls among the home-dwelling elderly by functional abilities. A prospective population-based study. Gerontology. 1998;44(4):232–238. [PubMed]
60. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988 Dec 29;319(26):1701–1707. [PubMed]
61. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. Jama. 1989 Dec 15;262(23):3303–3307. [PubMed]
62. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001 Dec;49(12):1685–1690. [PubMed]
63. Avidan AY, Fries BE, James ML, Szafara KL, Wright GT, Chervin RD. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc. 2005 Jun;53(6):955–962. [PubMed]
64. Bing MH, Moller LA, Jennum P, Mortensen S, Lose G. Pathophysiological aspects of nocturia in a Danish population of men and women age 60 to 80 years. J Urol. 2007;178:552–7. [PubMed]
65. Koseoglu H, Aslan G, Ozdemir, Esen A. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology. 2006;67:1188–92. [PubMed]